Home DeltaFlu Delta-19 About Vivaldi

News Publications Contact us

Home DeltaFlu Delta-19 About Vivaldi

News Publications Contact us

Scroll

“News”

Featured

Vivaldi Biosciences Announces Issuance of U.S. Patent Enabling Rapid Manufacture of its Universal Influenza Vaccine

Vivaldi Biosciences’ Universal Influenza Vaccine Shows Potential to Block Virus Transmission and Disease Spread

Vivaldi Biosciences to Present Universal Influenza Vaccine Data at World Vaccine Congress

Featured

News

News

Vivaldi Biosciences Announces Issuance of U.S. Patent Enabling Rapid Manufacture of its Universal Influenza Vaccine

Jul 21, 2025

Jul 21, 2025

Jul 21, 2025

Vivaldi Biosciences’ Universal Influenza Vaccine Shows Potential to Block Virus Transmission and Disease Spread

Apr 17, 2025

Apr 17, 2025

Apr 17, 2025

Dec 17, 2023

Dec 17, 2023

Dec 17, 2023

Jun 4, 2023

Jun 4, 2023

Jun 4, 2023

Vivaldi Biosciences to Present Universal Influenza Vaccine Data at World Vaccine Congress

Mar 28, 2023

Mar 28, 2023

Mar 28, 2023

Home DeltaFlu Delta-19 The need About Vivaldi News Publications Contact US

© Vivaldi Biosciences Inc. All Rights Reserved 2025

Vivaldi Biosciences is not interviewing to fill positions and is not hiring at this time. Beware of hiring scams that arrange online interviews, promptly offer a job, and ask for personal information such as your driver’s license number, social security number, or bank account information. If you believe you are a victim of a hiring scam you may notify the Federal Trade Commission: https://reportfraud.ftc.gov/ - /

Disclaimer: Delta NS1 vaccines are currently under clinical investigation and are not approved for human use in any country or region.